Global ConSeptS – Consultancy is an independent technical consultancy company that was established in 2008. The company specialises in aseptic processing and Quality by Design projects specific to the global bio-pharmaceutical industry. Our approach is pragmatic and to-the-point. You are our customer and we want you to get the best technical solution rather than a theoretical proposal. Although today Global ConSeptS is a one-man company, we want you to be best served. That is why we closely work together with other competent consultancy companies to provide you the best quality for your projects and assure you on-time delivery.
This is a FREE LISTING on PMHUB
Below are full profiles from other companies in related areas
Genesis Research Group empowers life science companies to innovate differently by fundamentally transforming the way they engage with research partners. Through the integration of robust stakeholder insights (RPR), data-agnostic expertise,…
We are a fully integrated agency that is 100% dedicated to creating standout communications in healthcare. Our success starts by strategically aligning promotion, medical education and PR across the product…
Advertising, Branding, Clinical Research, Conference/meetings/events, Creative and design, Digital communications, Management consultancies, Market access, Market research, Marketing consultancies, Medical communications, Medical education, Patient support and adherence, Public relations, Regulatory affairs
Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make a positive contribution to patient care. Real world experience of…
Company Details
Latest Content from PMHub
Press Releases | June 21, 2022 | Medscape Education
EHA2022 Hybrid Congress has now come to a close with the Thematic Days finishing last week. The Medscape team were delighted to connect with so many physicians, colleagues and supporters...
Press Releases | June 17, 2022 | Inizio
Headed up by Research Director, Angela McMean, the Evoke Mind+Matter Insights division comprises a team of primary research specialists focused on delivering meaningful, data-driven insight that supports the agency’s mission...
Videos and Podcasts | June 16, 2022 | Impetus Digital
Pam Cusick, Senior Vice President of Rare Patient Voice, dives into diversity, equity, and inclusion in Pharma and clinical trials; ways to enhance the patient’s voice in their treatment journey...
Press Releases | June 16, 2022 | Avalere Health
Fishawack Health bolsters its commercialization service offering with its largest addition to date, welcoming US-based policy, market access, and transformation leader Avalere.
Press Releases | June 16, 2022 | Cuttsy + Cuttsy
As official PIF Partners, Cuttsy+Cuttsy will be supporting the Patient Information Forum raise awareness of the PIF TICK.
White Papers and Resources | June 16, 2022 | Dice Medical Communications
Like great works of art, there was no ‘reason’ for certain scientific endeavours, but this ‘just for the sake of it’ philosophy is now delivering tangible benefits. (article written 3rd...
White Papers and Resources | June 15, 2022 | Page & Page Health
Mental health first aid can work as a vital steppingstone to instilling good mental health practices into wider company culture and ensure everyone knows what to be looking out for...
White Papers and Resources | June 15, 2022 | Innovative Trials
Each 14th June World Blood Donor day is celebrated around the world to spread awareness around the importance of giving blood.
Press Releases | June 13, 2022 | Wilmington Healthcare
Wilmington Healthcare’s State of the Nation prescribing report shows that spending on sertraline, commonly used to treat depression and anxiety, increased by 305.5% between 2019/20 and 2020/21 while overall spend...
Videos and Podcasts | June 13, 2022 | Innovative Trials
Patient recruitment is arguably one of the most important aspects of a clinical trial. Without enough participants, trials will inevitably fail, meaning potentially effective therapies will not be brought to...